Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (51-60 of 221) with videos related to

Pageof 23
Sort By:
Autoimmunity Reviews|October 14, 2014
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditisLuca Cantarini, Giuseppe Lopalco, Carlo Selmi, et al.
Clinical Rheumatology|June 3, 2016
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndromeDonato Rigante, Antonio Vitale, Marco Francesco Natale, et al.
Internal and Emergency Medicine|February 5, 2026
Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profileValeria Caggiano, Antonio Vitale, Jessica Sbalchiero, et al.
Medicine|October 27, 2015
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's DiseaseGiuseppe Lopalco, Orso Maria Lucherini, Antonio Vitale, et al.
Seminars in Arthritis and Rheumatism|October 17, 2025
Concomitant inflammatory bowel disease impairs biologic response and increases residual symptom burden in psoriatic arthritisMaria Morrone, Vincenzo Venerito, Maria Grazia Giannotta, et al.
Mediators of Inflammation|March 19, 2015
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesGiuseppe Lopalco, Luca Cantarini, Antonio Vitale, et al.
Seminars in Arthritis and Rheumatism|October 2, 2024
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activityGiuseppe Lopalco, Sergio Del Vescovo, Maria Morrone, et al.
Expert Opinion on Drug Safety|September 5, 2020
Safety of systemic treatments for Behçet's syndromeGiuseppe Lopalco, Donato Rigante, Antonio Lopalco, et al.
Clinical and Experimental Rheumatology|October 30, 2016
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndromeAntonio Vitale, Ida Orlando, Giuseppe Lopalco, et al.
International Journal of Molecular Sciences|April 28, 2023
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational StudyVincenzo Venerito, Pasquale Stefanizzi, Luca Cantarini, et al.
Pageof 23

Showing results (51-60 of 221) with videos related to

Sort By:
Pageof 23
Autoimmunity Reviews|October 14, 2014
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditisLuca Cantarini, Giuseppe Lopalco, Carlo Selmi, et al.
Clinical Rheumatology|June 3, 2016
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndromeDonato Rigante, Antonio Vitale, Marco Francesco Natale, et al.
Internal and Emergency Medicine|February 5, 2026
Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profileValeria Caggiano, Antonio Vitale, Jessica Sbalchiero, et al.
Medicine|October 27, 2015
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's DiseaseGiuseppe Lopalco, Orso Maria Lucherini, Antonio Vitale, et al.
Seminars in Arthritis and Rheumatism|October 17, 2025
Concomitant inflammatory bowel disease impairs biologic response and increases residual symptom burden in psoriatic arthritisMaria Morrone, Vincenzo Venerito, Maria Grazia Giannotta, et al.
Mediators of Inflammation|March 19, 2015
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesGiuseppe Lopalco, Luca Cantarini, Antonio Vitale, et al.
Seminars in Arthritis and Rheumatism|October 2, 2024
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activityGiuseppe Lopalco, Sergio Del Vescovo, Maria Morrone, et al.
Expert Opinion on Drug Safety|September 5, 2020
Safety of systemic treatments for Behçet's syndromeGiuseppe Lopalco, Donato Rigante, Antonio Lopalco, et al.
Clinical and Experimental Rheumatology|October 30, 2016
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndromeAntonio Vitale, Ida Orlando, Giuseppe Lopalco, et al.
International Journal of Molecular Sciences|April 28, 2023
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational StudyVincenzo Venerito, Pasquale Stefanizzi, Luca Cantarini, et al.
Pageof 23